Enzyme replacement therapy with agalsidase alfa in patients with Fabry's disease: an analysis of registry data

Mehta, A; Beck, M; Elliott, P; Guigliani, R; Linhart, A; Sunder-Plassmann, G; Schiffmann, R; Barbey, F; Ries, M; Clarke, JT; Fabry, Outcome survey Investigators; Huynh-Do, U (2009). Enzyme replacement therapy with agalsidase alfa in patients with Fabry's disease: an analysis of registry data. Lancet, 374(9706), pp. 1986-96. London: Elsevier 10.1016/S0140-6736(09)61493-8

Full text not available from this repository. (Request a copy)

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Dermatology, Urology, Rheumatology, Nephrology, Osteoporosis (DURN) > Clinic of Nephrology and Hypertension

UniBE Contributor:

Huynh-Do, Uyen

ISSN:

0140-6736

Publisher:

Elsevier

Language:

English

Submitter:

Factscience Import

Date Deposited:

04 Oct 2013 15:14

Last Modified:

04 May 2014 23:24

Publisher DOI:

10.1016/S0140-6736(09)61493-8

Web of Science ID:

000272727000022

URI:

https://boris.unibe.ch/id/eprint/32703 (FactScience: 198006)

Actions (login required)

Edit item Edit item
Provide Feedback